These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24030608)

  • 21. Agitation and aggressiveness among the elderly population living in nursing or retirement homes in France.
    Léger JM; Moulias R; Robert P; Vellas B; Chapuy PH; Monfort JC; Khoshnood B; Bouee S; Rebah N; Gerard D
    Int Psychogeriatr; 2002 Dec; 14(4):405-16. PubMed ID: 12670061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.
    Lopez OL; Wisniewski SR; Becker JT; Boller F; DeKosky ST
    Arch Neurol; 1999 Oct; 56(10):1266-72. PubMed ID: 10520944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes.
    Mueller C; John C; Perera G; Aarsland D; Ballard C; Stewart R
    Eur J Epidemiol; 2021 Jan; 36(1):89-101. PubMed ID: 32415541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.
    Devanand DP; Pelton GH; D'Antonio K; Strickler JG; Kreisl WC; Noble J; Marder K; Skomorowsky A; Huey ED
    Alzheimer Dis Assoc Disord; 2017; 31(1):73-75. PubMed ID: 27819842
    [No Abstract]   [Full Text] [Related]  

  • 25. Discontinuation of risperidone in Alzheimer's disease.
    Ling SM; Bonner AF; McMullen TL
    N Engl J Med; 2013 Jan; 368(2):187. PubMed ID: 23301740
    [No Abstract]   [Full Text] [Related]  

  • 26. Discontinuation of risperidone in Alzheimer's disease.
    Power GA
    N Engl J Med; 2013 Jan; 368(2):186-7. PubMed ID: 23301739
    [No Abstract]   [Full Text] [Related]  

  • 27. Discontinuation of risperidone in Alzheimer's disease.
    Gnjidic D; Hilmer SN
    N Engl J Med; 2013 Jan; 368(2):186. PubMed ID: 23301738
    [No Abstract]   [Full Text] [Related]  

  • 28. Discontinuation of risperidone in Alzheimer's disease.
    Devanand DP; Schultz SK; Sultzer DL
    N Engl J Med; 2013 Jan; 368(2):187-8. PubMed ID: 23301737
    [No Abstract]   [Full Text] [Related]  

  • 29. Involving the resident/decision maker in antipsychotic medication use.
    Mort JR
    S D Med; 2013 Apr; 66(4):148-9. PubMed ID: 23697039
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychotic symptoms, aggression and restlessness in dementia.
    Ballard C; Gray A; Ayre G
    Rev Neurol (Paris); 1999; 155 Suppl 4():S44-52. PubMed ID: 10637938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
    Weintraub D; Katz IR
    Psychiatr Clin North Am; 2005 Dec; 28(4):941-83, ix-x. PubMed ID: 16325736
    [No Abstract]   [Full Text] [Related]  

  • 32. New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis.
    Stahl SM
    CNS Spectr; 2018 Oct; 23(5):291-297. PubMed ID: 30382934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dementia and neuropsychiatric symptoms in nursing-home patients in Nord-Trøndelag County.
    Bergh S; Holmen J; Saltvedt I; Tambs K; Selbæk G
    Tidsskr Nor Laegeforen; 2012 Sep; 132(17):1956-9. PubMed ID: 23007358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To prescribe or not to prescribe? Atypical antipsychotic drugs in patients with dementia.
    Jeste DV; Meeks T
    South Med J; 2007 Oct; 100(10):961-3. PubMed ID: 17943030
    [No Abstract]   [Full Text] [Related]  

  • 35. Is the use of haloperidol a safe and effective method of tranquilization for patients with psychosis-induced aggression or agitation?
    Chandler A; Freeze-Ramsey R; Seupaul RA
    Ann Emerg Med; 2014 Jun; 63(6):757-8. PubMed ID: 24275570
    [No Abstract]   [Full Text] [Related]  

  • 36. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone for Psychosis-Induced Aggression or Agitation.
    Scruth E
    Issues Ment Health Nurs; 2019 Nov; 40(11):988-989. PubMed ID: 31381459
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.
    Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV
    Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ziprasidone for agitation or psychosis in dementia: four cases.
    Cole SA; Saleem R; Shea WP; Sedler M; Sablosky M; Jyringi D; Smith A
    Int J Psychiatry Med; 2005; 35(1):91-8. PubMed ID: 15977947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
    Reus VI; Fochtmann LJ; Eyler AE; Hilty DM; Horvitz-Lennon M; Jibson MD; Lopez OL; Mahoney J; Pasic J; Tan ZS; Wills CD; Rhoads R; Yager J
    Am J Psychiatry; 2016 May; 173(5):543-6. PubMed ID: 27133416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.